# BRAVO: Background Regimen of Raltegravir on Virologic Outcome

> **NCT00751530** · — · COMPLETED · sponsor: **Community Research Initiative of New England** · enrollment: 442 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** raltegravir

## Key facts

- **NCT ID:** NCT00751530
- **Lead sponsor:** Community Research Initiative of New England
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03-01
- **Primary completion:** 2009-06-15
- **Final completion:** 2009-06-15
- **Target enrollment:** 442 (ACTUAL)
- **Last updated:** 2017-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00751530

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00751530, "BRAVO: Background Regimen of Raltegravir on Virologic Outcome". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00751530. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*